As the Covington team discussed in a recent article, use of AI models in biopharma is on the rise, with use cases spanning the life cycle of drugs and biologics, including product development, manufacturing, and pharmacovigilance. Recently, FDA announced its own intentions to aggressively scale the use of AI in regulatory review and launched
About
Joy Chen is an associate in the firm's Boston office.
Latest Post
About
Joy Chen is an associate in the firm's Boston office.
Blogs
Firm/Org